TABLE 2.
Baseline demographics of the study cohort1
| Subject genotype | |||
|---|---|---|---|
| GG | GT | TT | |
| Female, % | 92 | 66.7 | 55.6 |
| n | 25 | 30 | 9 |
| Age, years | 39.7 ± 12.7 | 40.6 ± 11.7 | 41.3 ± 9.9 |
| Systolic BP | 110.1 ± 11.46 | 111.9 ± 13.0 | 113.1 ± 11.0 |
| Diastolic BP | 66.0 ± 7.04 | 69.3 ± 9.2 | 71.73 ± 9.9 |
| Resting HR | 66.6 ± 9.39 | 67.0 ± 12.7 | 70.3 ± 11.17 |
| Weight, kg | 65.0 ± 9.7 | 73.2 ± 11.0 | 71.9 ± 13.2 |
| Body fat, % | 29.6 ± 7.5 | 28.21 ± 9.4 | 25.8 ± 9.1 |
| BMI, kg/m2 | 23.2 ± 2.8 | 24.9 ± 2.9 | 24.4 ± 2.7 |
| Waist, cm | 69.7 ± 6.3 | 78.2 ± 7.9 | 76.3 ± 12.1 |
| Hip, cm | 94.8 ± 7.8 | 98.0 ± 6.4 | 96.2 ± 6.4 |
| Waist/hip ratio | 0.74 ± 0.04 | 0.80 ± 0.07 | 0.79 ± 0.08 |
1
Values are the means ± SDs at the visit 2 baseline before oil supplementation for the 64 participants who began the intervention. HR, heart rate.